Day | PELOD-2 score, survivors, median (IQR) | PELOD-2 score, non-survivors, median (IQR) | P value | Discrimination AUC (CI 95 %) | Calibrationa chi-square (p value) |
---|---|---|---|---|---|
1 | 4 (2–6) | 12 (8–18) | 0.0001 | 0.89 (0.86, 0.91) | 7.7 (0.47) |
2 | 3 (2–5) | 8 (5–15) | 0.0001 | 0.83 (0.78, 0.87) | 13.5 (0.06) |
5 | 3 (2–5) | 7 (5–10) | 0.0001 | 0.80 (0.75, 0.85) | 2.3 (0.89) |
8 | 3 (2–5) | 7 (5–9) | 0.0001 | 0.80 (0.73, 0.86) | 0.9 (0.99) |
12 | 3 (2–5) | 6 (5–8) | 0.0001 | 0.75 (0.67, 0.83) | 3.0 (0.80) |
16 | 3 (2–5) | 6 (4–8) | 0.0001 | 0.78 (0.69, 0.87) | 5.2 (0.51) |
18 | 3 (2–5) | 6 (5–8) | 0.0001 | 0.80 (0.72, 0.89) | 7.6 (0.27) |